{"id":9853,"date":"2019-10-28T17:35:12","date_gmt":"2019-10-28T15:35:12","guid":{"rendered":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad-2\/"},"modified":"2019-10-28T17:50:41","modified_gmt":"2019-10-28T15:50:41","slug":"epatopatie-e-obesita","status":"publish","type":"post","link":"https:\/\/kinepharma.es\/blog\/it\/2019\/10\/28\/epatopatie-e-obesita\/","title":{"rendered":"Epatopatie e obesit\u00e0"},"content":{"rendered":"<div style=\"text-align: justify;\"><a href=\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-9843\" src=\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad-1024x658.jpg\" alt=\"\" width=\"601\" height=\"386\" srcset=\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad-1024x658.jpg 1024w, https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad-300x193.jpg 300w, https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad-768x494.jpg 768w, https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg 1920w\" sizes=\"auto, (max-width: 601px) 100vw, 601px\" \/><br \/>\n<\/a><\/p>\n<p class=\"normal\"><span lang=\"IT\">Il consumo di bevande alcoliche cos\u00ec come una cattiva alimentazione costituiscono i principali nemici dello stato di salute del fegato. L&#8217;obesit\u00e0 \u00e8 una delle patologie che ha assunto connotazioni epidemiche nei paesi maggiormente sviluppati. Di fatto, secondo una ricerca effettuata su tale condizione patologica, si prevede che entro il 2030 in Spagna ben 27 milioni di persone saranno affette da obesit\u00e0 o in condizioni di sovrappeso, in Italia si calcola che per tale data almeno il 20 % della popolazione sar\u00e0 affetta da obesit\u00e0 e le persone in sovrappeso rappresenteranno il 50 % della stessa. Per tale motivo, \u00e8 necessario addentrarsi maggiormente nella problematica denominata fegato grasso (steatosi epatica) e nel rapporto che intercorre tra questa patologia e l&#8217;obesit\u00e0.<\/span><\/p>\n<h2><strong>In cosa consiste la steatosi epatica non alcolica<\/strong>?<\/h2>\n<p class=\"normal\"><span lang=\"IT\">La steatosi epatica non alcolica, comunemente nota come fegato grasso, \u00e8 determinata dall\u2019accumulo in eccesso di grassi (in particolare i trigliceridi) nell&#8217;addome. Le aree epatiche possono accumulare lipidi in persone che consumano poco o affatto bevande alcoliche. La ragione di tale fenomeno \u00e8 riconducibile essenzialmente alla cattiva alimentazione. Un&#8217;abitudine non salutare che pu\u00f2 essere altrettanto pericolosa quanto il consumo eccessivo di bevande alcoliche. <\/span><\/p>\n<p class=\"normal\"><span lang=\"IT\">Nella nostra societ\u00e0, le epatopatie lipidiche non alcoliche sono abbastanza comuni. Il 20 % delle persone colpite \u00e8 costituito da adulti e il 5 % da bambini. Questi dati sono alquanto allarmanti se si considerano le possibili conseguenze per la salute di questa condizione patologica. <\/span><\/p>\n<p class=\"normal\"><span lang=\"IT\">Quali sono le cause delle epatopatie lipidiche non alcoliche? Si tratta principalmente di una sindrome metabolica caratterizzata dalla comparsa del diabete (insulino-resistenza), del colesterolo, dell&#8217;obesit\u00e0 e dell&#8217;ipertensione. I medici specialisti hanno identificato le principali cause della steatosi epatica:<\/span><\/p>\n<ul>\n<li>Lo stress ossidativo. In altri termini, \u00e8 il disequilibrio tra le sostanze chimiche che pu\u00f2 danneggiare le cellule epatiche.<\/li>\n<li>La produzione da parte delle cellule epatiche del paziente di proteine flogistiche tossiche.<\/li>\n<li>L&#8217;apoptosi o la morte delle cellule epatiche.<\/li>\n<\/ul>\n<h2><strong>Rischi derivanti dalla steatosi epatica non alcolica<\/strong><\/h2>\n<p><a href=\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-obesidad-PORTADA.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-9844\" src=\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-obesidad-PORTADA-1024x629.jpg\" alt=\"\" width=\"601\" height=\"369\" srcset=\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-obesidad-PORTADA-1024x629.jpg 1024w, https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-obesidad-PORTADA-300x184.jpg 300w, https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-obesidad-PORTADA-768x472.jpg 768w, https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-obesidad-PORTADA.jpg 1600w\" sizes=\"auto, (max-width: 601px) 100vw, 601px\" \/><\/a><\/p>\n<p class=\"normal\"><span lang=\"IT\">Quando una persona si alimenta in modo scorretto per lungo tempo, il grasso si accumula in maniera tale che l&#8217;infiammazione si manifesta nel fegato. Se tale complicanza per la salute non viene rilevata in tempo utile, pu\u00f2 causare una patologia denominata cirrosi epatica o la morte di gran parte del tessuto epatico. <\/span><\/p>\n<p class=\"normal\"><span lang=\"IT\">La steatosi epatica non alcolica \u00e8 una patologia che pu\u00f2 divenire reversibile, poich\u00e9 il fegato ha la capacit\u00e0 di auto-rigenerarsi. Se il paziente non adotta le indicazioni del proprio medico, corre il rischio di:<\/span><\/p>\n<ul>\n<li>Sviluppare una patologia ipertensiva.<\/li>\n<li>Incorrere in un ictus.<\/li>\n<li>Incrementare la probabilit\u00e0 di contrarre patologie tumorali.<\/li>\n<li>Sviluppare il diabete di tipo 2.<\/li>\n<\/ul>\n<p>Una prima azione terapeutica nei confronti della steatosi epatica non alcolica consiste in un cambiamento radicale nella dieta del paziente con l&#8217;obiettivo di perdere peso. La scelta \u00e8 orientata a un&#8217;alimentazione equilibrata a base di fibre, proteine, frutta, verdura, ma anche carni e prodotti ittici a basso contenuto di grassi. L&#8217;esercizio fisico rappresenter\u00e0 il complemento obbligatorio di questa nuova routine alimentare.<\/p>\n<p>Per controllare lo stato di salute epatico possiamo servirci del<a href=\"http:\/\/www.kinepharma.es\/es\/kits-enfermedades\/92-test-enfermedades-higado-y-vesicula-biliar.html\"> <strong>kit relativo alle malattie del fegato e della cistifellea<\/strong><\/a>, in particolare possiamo testare, tra le altre, le fiale riferite alla steatosi epatica non alcolica e alla cirrosi epatica o biliare.<\/p>\n<\/div>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>Il consumo di bevande alcoliche cos\u00ec come una cattiva alimentazione costituiscono i principali nemici dello stato di salute del fegato. L&#8217;obesit\u00e0 \u00e8 una delle patologie che ha assunto connotazioni epidemiche [&hellip;]<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":1,"featured_media":9843,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[3691,3692,3693,3689,3690],"class_list":["post-9853","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kinesiologia","tag-cardiovascular","tag-diabetes-de-tipo-2","tag-esteatosis-hepatica","tag-higado-graso","tag-hipertension"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Epatopatie e obesit\u00e0 - Blog sobre kinesiolog\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epatopatie e obesit\u00e0 - Blog sobre kinesiolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Il consumo di bevande alcoliche cos\u00ec come una cattiva alimentazione costituiscono i principali nemici dello stato di salute del fegato. L&#8217;obesit\u00e0 \u00e8 una delle patologie che ha assunto connotazioni epidemiche [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog sobre kinesiolog\u00eda\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-28T15:35:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-28T15:50:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1234\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Angel Salazar Maga\u00f1a\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@kinepharma\" \/>\n<meta name=\"twitter:site\" content=\"@kinepharma\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Angel Salazar Maga\u00f1a\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/\"},\"author\":{\"name\":\"Angel Salazar Maga\u00f1a\",\"@id\":\"https:\/\/kinepharma.es\/blog\/#\/schema\/person\/485449e8a6e8a193503a672968ee1e45\"},\"headline\":\"Epatopatie e obesit\u00e0\",\"datePublished\":\"2019-10-28T15:35:12+00:00\",\"dateModified\":\"2019-10-28T15:50:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/\"},\"wordCount\":512,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg\",\"keywords\":[\"cardiovascular\",\"diabetes de tipo 2\",\"esteatosis hep\u00e1tica\",\"h\u00edgado graso\",\"hipertensi\u00f3n\"],\"articleSection\":[\"Kinesiolog\u00eda\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/\",\"url\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/\",\"name\":\"Epatopatie e obesit\u00e0 - Blog sobre kinesiolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg\",\"datePublished\":\"2019-10-28T15:35:12+00:00\",\"dateModified\":\"2019-10-28T15:50:41+00:00\",\"author\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/#\/schema\/person\/485449e8a6e8a193503a672968ee1e45\"},\"breadcrumb\":{\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage\",\"url\":\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg\",\"contentUrl\":\"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg\",\"width\":1920,\"height\":1234},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/kinepharma.es\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Epatopatie e obesit\u00e0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kinepharma.es\/blog\/#website\",\"url\":\"https:\/\/kinepharma.es\/blog\/\",\"name\":\"Blog sobre kinesiolog\u00eda\",\"description\":\"Blog relacionado con el mundo de la kinesiolog\u00eda y de los materiales para su pr\u00e1ctica\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kinepharma.es\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/kinepharma.es\/blog\/#\/schema\/person\/485449e8a6e8a193503a672968ee1e45\",\"name\":\"Angel Salazar Maga\u00f1a\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/f7f2a54851f8c55a440d50e49d015adbf660419a165fb46f71d520ac5373c9e7?s=96&d=retro&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f7f2a54851f8c55a440d50e49d015adbf660419a165fb46f71d520ac5373c9e7?s=96&d=retro&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f7f2a54851f8c55a440d50e49d015adbf660419a165fb46f71d520ac5373c9e7?s=96&d=retro&r=g\",\"caption\":\"Angel Salazar Maga\u00f1a\"},\"description\":\"Kinesiologo Hol\u00edstico y empresario, socio de Kinepharma.es.\",\"sameAs\":[\"http:\/\/www.kinepharma.es\",\"https:\/\/x.com\/kinepharma\"],\"url\":\"https:\/\/kinepharma.es\/blog\/author\/angel\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epatopatie e obesit\u00e0 - Blog sobre kinesiolog\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/","og_locale":"es_ES","og_type":"article","og_title":"Epatopatie e obesit\u00e0 - Blog sobre kinesiolog\u00eda","og_description":"Il consumo di bevande alcoliche cos\u00ec come una cattiva alimentazione costituiscono i principali nemici dello stato di salute del fegato. L&#8217;obesit\u00e0 \u00e8 una delle patologie che ha assunto connotazioni epidemiche [&hellip;]","og_url":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/","og_site_name":"Blog sobre kinesiolog\u00eda","article_published_time":"2019-10-28T15:35:12+00:00","article_modified_time":"2019-10-28T15:50:41+00:00","og_image":[{"width":1920,"height":1234,"url":"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg","type":"image\/jpeg"}],"author":"Angel Salazar Maga\u00f1a","twitter_card":"summary_large_image","twitter_creator":"@kinepharma","twitter_site":"@kinepharma","twitter_misc":{"Escrito por":"Angel Salazar Maga\u00f1a","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#article","isPartOf":{"@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/"},"author":{"name":"Angel Salazar Maga\u00f1a","@id":"https:\/\/kinepharma.es\/blog\/#\/schema\/person\/485449e8a6e8a193503a672968ee1e45"},"headline":"Epatopatie e obesit\u00e0","datePublished":"2019-10-28T15:35:12+00:00","dateModified":"2019-10-28T15:50:41+00:00","mainEntityOfPage":{"@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/"},"wordCount":512,"commentCount":0,"image":{"@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage"},"thumbnailUrl":"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg","keywords":["cardiovascular","diabetes de tipo 2","esteatosis hep\u00e1tica","h\u00edgado graso","hipertensi\u00f3n"],"articleSection":["Kinesiolog\u00eda"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/","url":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/","name":"Epatopatie e obesit\u00e0 - Blog sobre kinesiolog\u00eda","isPartOf":{"@id":"https:\/\/kinepharma.es\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage"},"image":{"@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage"},"thumbnailUrl":"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg","datePublished":"2019-10-28T15:35:12+00:00","dateModified":"2019-10-28T15:50:41+00:00","author":{"@id":"https:\/\/kinepharma.es\/blog\/#\/schema\/person\/485449e8a6e8a193503a672968ee1e45"},"breadcrumb":{"@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#primaryimage","url":"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg","contentUrl":"https:\/\/kinepharma.es\/blog\/wp-content\/uploads\/2019\/10\/enfermedades-higado-y-obesidad.jpg","width":1920,"height":1234},{"@type":"BreadcrumbList","@id":"https:\/\/kinepharma.es\/blog\/2019\/10\/28\/enfermedades-hepaticas-y-obesidad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/kinepharma.es\/blog\/"},{"@type":"ListItem","position":2,"name":"Epatopatie e obesit\u00e0"}]},{"@type":"WebSite","@id":"https:\/\/kinepharma.es\/blog\/#website","url":"https:\/\/kinepharma.es\/blog\/","name":"Blog sobre kinesiolog\u00eda","description":"Blog relacionado con el mundo de la kinesiolog\u00eda y de los materiales para su pr\u00e1ctica","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kinepharma.es\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/kinepharma.es\/blog\/#\/schema\/person\/485449e8a6e8a193503a672968ee1e45","name":"Angel Salazar Maga\u00f1a","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/f7f2a54851f8c55a440d50e49d015adbf660419a165fb46f71d520ac5373c9e7?s=96&d=retro&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f7f2a54851f8c55a440d50e49d015adbf660419a165fb46f71d520ac5373c9e7?s=96&d=retro&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f7f2a54851f8c55a440d50e49d015adbf660419a165fb46f71d520ac5373c9e7?s=96&d=retro&r=g","caption":"Angel Salazar Maga\u00f1a"},"description":"Kinesiologo Hol\u00edstico y empresario, socio de Kinepharma.es.","sameAs":["http:\/\/www.kinepharma.es","https:\/\/x.com\/kinepharma"],"url":"https:\/\/kinepharma.es\/blog\/author\/angel\/"}]}},"_links":{"self":[{"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/posts\/9853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/comments?post=9853"}],"version-history":[{"count":2,"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/posts\/9853\/revisions"}],"predecessor-version":[{"id":9860,"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/posts\/9853\/revisions\/9860"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/media\/9843"}],"wp:attachment":[{"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/media?parent=9853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/categories?post=9853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kinepharma.es\/blog\/wp-json\/wp\/v2\/tags?post=9853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}